Supernus Pharmaceuticals, Inc. (SUPN)
49.67
-0.22
(-0.44%)
USD |
NASDAQ |
Dec 31, 16:00
49.67
0.00 (0.00%)
After-Hours: 19:45
Supernus Pharmaceuticals Market Cap: 2.848B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BridgeBio Pharma, Inc. | 14.74B |
| The Cooper Cos., Inc. | 16.06B |
| Assembly Biosciences, Inc. | 537.78M |
| Amphastar Pharmaceuticals, Inc. | 1.231B |
| Viking Therapeutics, Inc. | 3.974B |
Market Cap Related Metrics
| PS Ratio | 4.109 |
| Price to Book Value | 2.713 |
| Price to Free Cash Flow | 39.58 |
| Price | 49.67 |
| Earnings Yield | -0.69% |